TRNS (Transcat) ROCE % : 7.63% (As of Mar. 2025)

View and export this data going back to 1977. Start your Free Trial

What is Transcat ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Transcat's annualized ROCE % for the quarter that ended in Mar. 2025 was 7.63%.

Transcat ROCE % Historical Data

The historical data trend for Transcat's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcat ROCE % Chart

Transcat Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

ROCE %

Get a 7-Day Free Trial

10.34

10.89

10.02

9.62

6.32

Transcat Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROCE %	Get a 7-Day Free Trial															15.27	7.74	5.15	4.09	7.63

Transcat ROCE % Calculation

Transcat's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2025 )		(A: Mar. 2024 )		(A: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2025 )		(A: Mar. 2024 )		(A: Mar. 2025 )
	=	19.124	/	( ( (287.552 - 33.499)	+	(385.242 - 34.037) )	/ 2 )
	=	19.124	/	( (254.053	+	351.205)	/ 2 )
	=	19.124	/	302.629
	=	6.32 %

Transcat's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	26.908	/	( ( (386.009 - 31.679)	+	(385.242 - 34.037) )	/ 2 )
	=	26.908	/	( ( 354.33	+	351.205 )	/ 2 )
	=	26.908	/	352.7675
	=	7.63 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

Transcat (NAS:TRNS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Transcat ROCE % Related Terms

Thank you for viewing the detailed overview of Transcat's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Transcat Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Transcat Inc (NAS:TRNS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

TR8:Germany

Address

35 Vantage Point Drive, Rochester, NY, USA, 14624

Website

https://www.transcat.com

Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.

Executives

Craig D. Cairns	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Christopher P. Gillette	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Charles P Hadeed	officer: VP-Finance and CFO	35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
James M. Jenkins	officer: Gen Counsel & VP of Corp Devt	1600 BAUSCH & LOMB PLACE, ROCHESTER NY 14604
Lee D. Rudow	officer: Chief Operating Officer	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Dawn Deperrior	director	45 SOUTH MAIN STREET, FAIRPORT NY 14450
Scott Deverell	other: Principal Accounting Officer	100 CHESTNUT STREET, SUITE 600, ROCHESTER NY 14604
Richard J Harrison	director	44 SOUTHERN PARKWAY, ROCHESTER NY 14618
Theresa A. Conroy	officer: VP, Human Resources	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Cynthia Langston	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Thomas L Barbato	officer: Sr. VP Finance & CFO	105 NORTON STREET, NEWARK NY 14513
Carl E Sassano	director, officer: Chairman, President and CEO	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Gary J. Haseley	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Michael W. West	officer: VP Distribution & Marketing	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Mbago M. Kaniki	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624